It may also be prescribed for people with a BMI of 27 or higher who also have weight-related health issues such as high blood pressure, high cholesterol, or type 2 diabetes
These findings not only validate the clinical potential of GCG/GLP-1 dual receptor agonists, but also highlight the continued evolution of multi-target metabolic therapies in diabesity treatment
This means you start at a very low dose and gradually increase it every four weeks
Research has shown that by reducing systemic inflammation, Semaglutide may help lower the risk of heart disease and stroke
Over multiple draws from a single vial, dead volume losses accumulate
Rapid or sudden weight gain with swelling, breathlessness, or chest pain requires urgent assessment via NHS 111 or 999